Servier and Day One Biopharmaceuticals announced an acquisition to expand Servier's portfolio in rare oncology. Did you miss out on the acquisition price of $21.50?😂$Day One Biopharmaceuticals(DAWN.US)
Share your thoughtsWhat's on your mind?
0 / 2,000
- D
Rivian: Narrowing Losses, R2 Mass Production Imminent, Is Rivian's Dawn Approaching?
Successfully climbed out of the second quarter loss mire
+3
RivianFinancial Analysis